
These companies are poised to thrive as data centers require more electricity than ever before.
Apenas manchetes de alto sinal - eventos macro, resultados, M&A, regulatório. Listicles e clickbait de analistas filtrados por padrão. Atualizado a cada hora.

These companies are poised to thrive as data centers require more electricity than ever before.
Nebius just announced its third major debt issue in a year to support its massive AI infrastructure expansion.

You could do a thought experiment to gauge your appetite for outsize holdings, says Cindy Wilson, a certified financial planner at HB Wealth in Alpharetta, Ga. For example, if a client was sitting on a $500,000 position in Apple Wilson would ask, what if they had $500,000 in cash instead? Before deciding whether to sell, consider how much capital-gains tax you may owe if you sell shares in a taxable account.

In August 2026, Regeneron Pharmaceuticals announced that the US FDA approved Pasatru (garetosmab-grts) to reduce new heterotopic ossification lesions and flare-ups in adults with fibrodysplasia ossificans progressiva, based on positive Phase 3 OPTIMA trial results. This approval adds a rare-disease monoclonal antibody to Regeneron’s portfolio, reinforcing the company’s focus on specialized, high-complexity immunology therapies. We’ll now examine how Pasatru’s FOP approval, as an ultra-rare...

The share count hasn't budged since March. The value more than tripled. The difference matters for anyone who owns the chipmaker's stock.

Investors are excited about a lucrative chip supply deal with an AI titan.

The 40-year veteran fund manager resets his Nvidia forecast for the rest of the year.

Big Tech's AI data center spree still needs power and hardware. Three industrial stocks positioned to benefit: Caterpillar, Eaton, GE Vernova.

The two numbers are about $1 billion apart. What the chipmaker's guide assumes about China and margins says more than the gap does.

The biotech could be on the verge of setting a new standard of care for skin cancer.

Its favorite commodities staged a surprise Hump Day rally.

Triple-leveraged semiconductor exposure sounds like a recipe for disaster, yet one ETF quietly turned a modest stake into something that rivals a year of aggressive trading. The math behind it challenges almost everything conventional wisdom says about managing risk.

Consider investing in Lockheed for the long haul rather than playing a timing game with a stock split.

An analyst raised his price target on the company by more than 33%.

Three assets. One $1,000 entry. Eleven years. The answer is not what most people expect.

A fund from the same shop that built one of the most popular Nasdaq income ETFs just entered the pipeline space, and it is quietly paying out a yield that makes the category's longtime leader look almost stingy by comparison.

Q2 earnings performance significantly exceeded recent historical baselines, with both growth rates and beat percentages tracking comfortably above 20-quarter averages. Even when excluding hefty contributions from Micron and Alphabet, the overall Q2 earnings picture remained rock-solid.

NEOS built its reputation on a flagship S&P 500 income ETF that clears 12% annually, but a pair of younger siblings run the same playbook at a noticeably different intensity, and the tradeoffs are not what most income investors expect.

The Model Y L targets a missing customer.
The next test is whether strength extends into 2027

Some of America’s biggest tech stocks have been flashing a bullish signal lately, according to Morgan Stanley.

Minutes from the Federal Open Market Committee's July 28-29 meeting show uneasiness among members regarding inflation.

VUG's rock-bottom fee gets all the attention, but a hidden cost in the fund's structure quietly shapes every dollar you invest in ways most holders never stop to calculate.

These two stocks both have market caps of more than $1 trillion, but Eli Lilly's valuation is supported by strong financials.

Moby summary of Lowe's Companies, Inc.'s Q2 2027 earnings call

NVIDIA Corporation (NASDAQ:NVDA) is heading into its August 26 earnings report with expectations already elevated. Wall Street firm Stifel believes it can clear this high bar, with its bull case built around independent checkpoints scattered across the supply chain. On August 19, Stifel analyst Ruben Roy reiterated a Buy rating on the stock with a […]

Moby summary of Marti Technologies, Inc.'s Q2 2026 earnings call
We use Google Analytics to count anonymous page views and understand which content gets read. No ads, no profiles. Decline keeps you on cookieless mode. Details.